Alvotech

Alvotech Completes Second Round of a US$100 Million Private Placement

March 15, 2021 Marie Jones

Multinational biopharmaceutical company Alvotech has successfully completed a second round of its US$100 million private placement, for US$35 million. The first round which was completed in October 2020, amounted to…

BioTech HealthCare

Alvotech and Cipla Gulf Expand Partnership for Commercialization of Biosimilars in Australia and New Zealand

March 4, 2021 Marie Jones

Multinational biopharmaceutical company Alvotech and Gulf FZ LCC (“Cipla Gulf”), subsidiary of Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced that they are expanding their…

Alvotech Completes Second Round of a US$100 Million Private Placement

Alvotech and Cipla Gulf Expand Partnership for Commercialization of Biosimilars in Australia and New Zealand

You missed

GMG’s G(R) LUBRICANT and THERMAL-XR(R) to be Distributed by Blackwoods in Australia

AI-driven Demand Sustains Robust Growth of Hong Kong’s June Exports

ATAL Wins the Theme Award of BDO ESG Awards

Ausnutria 2026 Interim Profit Alert: Revenue Expected to Reach Approximately RMB3.065 billion to RMB3.165 billion, with Core Business Fundamentals Remaining Stable

Tag: Alvotech

Alvotech Completes Second Round of a US$100 Million Private Placement

Alvotech and Cipla Gulf Expand Partnership for Commercialization of Biosimilars in Australia and New Zealand

You missed

GMG’s G(R) LUBRICANT and THERMAL-XR(R) to be Distributed by Blackwoods in Australia

AI-driven Demand Sustains Robust Growth of Hong Kong’s June Exports

ATAL Wins the Theme Award of BDO ESG Awards

Ausnutria 2026 Interim Profit Alert: Revenue Expected to Reach Approximately RMB3.065 billion to RMB3.165 billion, with Core Business Fundamentals Remaining Stable